| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/13/2013 | US8507495 Sensitizer, kit and use for cancer therapy |
| 08/13/2013 | US8507494 Heterocyclic quinolizine derived M1 receptor positive allosteric modulators |
| 08/13/2013 | US8507493 Amide and amidine derivatives and uses thereof |
| 08/13/2013 | US8507492 Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway |
| 08/13/2013 | US8507491 Compounds and compositions as hedgehog pathway inhibitors |
| 08/13/2013 | US8507490 Tetrasubstituted pyridazine hedgehog pathway antagonists |
| 08/13/2013 | US8507489 Bicyclic triazoles as protein kinase modulators |
| 08/13/2013 | US8507488 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| 08/13/2013 | US8507487 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor |
| 08/13/2013 | US8507486 Pyridopyrazine derivatives, process of manufacturing and uses thereof |
| 08/13/2013 | US8507485 Cyclic compound having pyrimidinylalkylthio group |
| 08/13/2013 | US8507484 Preventive and/or therapeutic agent for neutrophilic inflammatory diseases |
| 08/13/2013 | US8507483 1H-pyrimidin-2-one derivatives, preparation thereof and pharmaceutical use thereof as inhibitors of AKT (PKB) phosphorylation |
| 08/13/2013 | US8507482 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses |
| 08/13/2013 | US8507481 Benzoxazine oxazolidinone compounds, preparation methods and uses thereof |
| 08/13/2013 | US8507480 Isoxazole compounds as inhibitors of heat shock proteins |
| 08/13/2013 | US8507479 Aminodihydrothiazine derivatives substituted with a cyclic group |
| 08/13/2013 | US8507478 Oxazolidinyl antibiotics |
| 08/13/2013 | US8507477 3- and 6-quinolines with N-attached heterocyclic CGRP receptor antagonists |
| 08/13/2013 | US8507476 Substituted arylamide diazepinopyrimidone derivatives |
| 08/13/2013 | US8507475 Substituted heteroarylamide diazepinopyrimidone derivatives |
| 08/13/2013 | US8507474 Anthelmintic agents and their use |
| 08/13/2013 | US8507473 3H-imidazo[4,5-b]pyridin-5-ol derivatives useful in the treatment of GPR81 receptor disorders |
| 08/13/2013 | US8507469 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor |
| 08/13/2013 | US8507468 Intranasal anti-convulsive compositions and methods |
| 08/13/2013 | US8507467 Transdermally absorbable preparation |
| 08/13/2013 | US8507466 Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy |
| 08/13/2013 | US8507465 Antiemetic-oral contraceptive combination |
| 08/13/2013 | US8507464 Phosphoramidate alkylator prodrugs |
| 08/13/2013 | US8507463 Nucleotide analogue prodrug and the preparation thereof |
| 08/13/2013 | US8507462 Compositions and uses thereof |
| 08/13/2013 | US8507461 Non-absorbable non-digestible polymer compounds |
| 08/13/2013 | US8507460 Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections |
| 08/13/2013 | US8507459 Use of adenosine aspartate for the preparation of pharmaceutical products for the treatment of liver cancer |
| 08/13/2013 | US8507458 System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron |
| 08/13/2013 | US8507454 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 08/13/2013 | US8507453 Anti-penicillin resistant pneumococci agent and novel 16-membered macrolide derivative |
| 08/13/2013 | US8507452 Hesperidin-containing composition |
| 08/13/2013 | US8507451 Method for the treatment of type II diabetes |
| 08/13/2013 | US8507450 Crystalline forms of 1-chloro-4-(β-D-glucopyranos-1-yl)-2-[4-ethynyl-benzyl)-benzene, methods for its preparation and the use thereof for preparing medicaments |
| 08/13/2013 | US8507443 Anticancer agent |
| 08/13/2013 | US8507437 Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same |
| 08/13/2013 | US8507430 Methods for administering FGF18 |
| 08/13/2013 | US8507411 Neoglycorandomization and digitoxin analogs |
| 08/13/2013 | US8507409 Synergistic combination of a glyphosate compound and DMITS |
| 08/13/2013 | US8507408 Synergistic combination of a glyphosate compound and one of DCOIT or OIT or BBIT |
| 08/13/2013 | US8507219 Method of treating inflammation with statins |
| 08/13/2013 | US8507018 Foods, drug containing cocoa and proanthocyanidin; adjust concentration of nitrogen oxide; hypotensive agents; cardiovascular disorders |
| 08/13/2013 | US8507017 Desensitizing nicotinic acetylcholine receptors using tetrahydroberberine containing plant extract; blocking dopamine release |
| 08/13/2013 | US8507013 Compositions for controlling insects |
| 08/13/2013 | US8507010 Compositions comprising quinazoline derivatives |
| 08/13/2013 | US8507009 Colonic purgative composition with soluble binding agent |
| 08/13/2013 | US8507005 Particulates of a CRTH2 antagonist |
| 08/13/2013 | US8507003 Compressed tablets comprising microcapsules with modified release |
| 08/13/2013 | US8507000 Controlled release formulation of erythromycin derivatives |
| 08/13/2013 | US8506998 Pharmaceutical formulation |
| 08/13/2013 | US8506997 Pharmaceutical compound containing silymarin and carbopol, its manufacturing process and its use as a regenerator of the pancreatic tissue and cells of endogenous secretion damaged by diabetes mellitus |
| 08/13/2013 | US8506992 Percutaneous absorption-type pharmaceutical preparations |
| 08/13/2013 | US8506991 Nicotine transdermal preparation and production method thereof |
| 08/13/2013 | US8506990 Local administration of gallium compositions to treat pain |
| 08/13/2013 | US8506989 Preparation comprising a creatine component, method for the production thereof, and the use thereof |
| 08/13/2013 | US8506987 Ocular implant made by a double extrusion process |
| 08/13/2013 | US8506986 Associated with diabetes; implanting an alpha-2 adrenergic receptor agonist, such as brimonidine, associated with a biodegradable polymer matrix; hypotensive agents, antiischemic agents; glaucoma |
| 08/13/2013 | US8506984 Therapeutic agent elution control process |
| 08/13/2013 | US8506945 Polymers with structure-defined functions |
| 08/13/2013 | US8506935 Respiratory drug condensation aerosols and methods of making and using them |
| 08/13/2013 | US8506926 [18F]-furanosylpurine derivatives and uses thereof |
| 08/13/2013 | US8506859 Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene |
| 08/13/2013 | CA2768841C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768828C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768773C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2743019C Akt and p70 s6 kinase inhibitors |
| 08/13/2013 | CA2738878C Selective estrogen receptor modulator for the treatment of osteoarthritis |
| 08/13/2013 | CA2706354C Use of hydrogen fumarate and dihydrogen phosphate salts of meldonium in treating or preventing atherosclerosis |
| 08/13/2013 | CA2690753C Sulfonamide compound and crystal thereof |
| 08/13/2013 | CA2684563C 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-ht7 receptor antagonists |
| 08/13/2013 | CA2683914C Oligo-guluronate and galacturonate compositions |
| 08/13/2013 | CA2673809C Thioxanthene derivates useful to treat infectious diseases |
| 08/13/2013 | CA2670892C Substituted diazepan compounds as orexin receptor antagonists |
| 08/13/2013 | CA2666063C Compositions suitable for the topical treatment of fungal infections of the skin and nails |
| 08/13/2013 | CA2655138C Compositions comprising chitin microparticles and their medical uses |
| 08/13/2013 | CA2649822C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 08/13/2013 | CA2634149C Novel hydrogen sulfate salt for use in the treatment of hyperproliferative diseases |
| 08/13/2013 | CA2629348C Glucagon receptor antagonists, preparation and therapeutic uses |
| 08/13/2013 | CA2627363C Compounds for the treatment of insulin resistance syndrome and diabetes |
| 08/13/2013 | CA2621059C Stabilized protease composition |
| 08/13/2013 | CA2619566C 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 08/13/2013 | CA2619448C 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 08/13/2013 | CA2613365C Phenoxy acetic acids as ppar delta activators |
| 08/13/2013 | CA2611892C Tetrahydroquinoline derivatives as motor protein eg5 inhibitors and antitumor agents |
| 08/13/2013 | CA2606473C Benzisoxazole piperazine compounds and methods of use thereof |
| 08/13/2013 | CA2599953C Novel c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
| 08/13/2013 | CA2594320C Method for producing l-biopterin |
| 08/13/2013 | CA2593140C Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2b (ugt2b) |
| 08/13/2013 | CA2592474C Prostaglandin f2.alpha. derivative-containing product |
| 08/13/2013 | CA2589748C Heterocyclic compounds as ccr2b antagonists |
| 08/13/2013 | CA2589102C Pyridazine compounds and methods for using the compounds to treat inflammatory diseases |
| 08/13/2013 | CA2580409C Triazole derivative or salt thereof |
| 08/13/2013 | CA2578052C Methods of activating nkt cells |
| 08/13/2013 | CA2571462C Composition for preventing recurrence of stroke |